Feeds
55027 items (55027 unread) in 74 feeds
Acinar Cell Carcinoma
(338 unread)
Acinic Cell Carcinoma
(251 unread)
Adenoid Cystic Carcinoma
(1053 unread)
Adrenal Gland Cancer
(4917 unread)
Ampulla Of Vater
(1143 unread)
Anal Cancer
(5360 unread)
Angiosarcoma
(1632 unread)
Appendix Cancer
(787 unread)
Bile Duct Cancer
(7076 unread)
Brain and CNS
(7294 unread)
Carcinoid
(2329 unread)
Endocrine/Neuroendocrine
(5803 unread)
Gall Bladder Cancer
(2543 unread)
Hemangioendothelioma
(791 unread)
Hepatoblastoma
(767 unread)
Pancreas
(758 unread)
Phyllodes
(417 unread)
PMP and Mucinous Tumors
(474 unread)
Rhabdomyosarcoma
(2175 unread)
Sarcoma
(9119 unread)
Google - Appendix Cancer (5 unread)
-
Blue Earth's Oelke family battles a rare appendix cancer - faribaultcountyregister.com | News, Sports, Information on the Blue Earth region - Faribault County Register
Posted: June 11th, 2017, 5:00am GMT
-
Review of appendix cancer cases finds over-diagnosis - Science Daily
Posted: June 8th, 2017, 5:00am GMT
Review of appendix cancer cases finds over-diagnosis Science Daily -
Review of appendix cancer cases finds over diagnosis - Medical Xpress
Posted: June 8th, 2017, 5:00am GMT
Review of appendix cancer cases finds over diagnosis Medical XpressLesions of the appendix are being over diagnosed as invasive cancer, report University of California San Diego School of Medicine researchers in a paper ...
-
Review of Appendix Cancer Cases Finds Over Diagnosis - UC San Diego Health
Posted: June 7th, 2017, 5:00am GMT
Review of Appendix Cancer Cases Finds Over Diagnosis UC San Diego Health -
Loxo Oncology to Seek FDA Approval for Pan-Cancer Drug in Patients with TRK Fusions - GenomeWeb
Posted: June 3rd, 2017, 5:00am GMT
Loxo Oncology to Seek FDA Approval for Pan-Cancer Drug in Patients with TRK Fusions GenomeWebData presented at ASCO showing 76 percent of cancer patients responded to larotrectinib could lead to the availability of the first tissue-agnostic targeted drug.